Repligen Corporation
Repligen Corporation is a life sciences technology company that develops and manufactures bioprocessing products used in the production of biologic drugs, including monoclonal antibodies, gene therapies, and vaccines. It sells filtration, chromatography, process analytics, and fluid management solutions to biopharmaceutical manufacturers and contract development and manufacturing organizations worldwide. The company generates revenue through the sale of equipment, consumables, and related technologies used across upstream and downstream bioprocessing workflows.
- Revenue
- $640.0M
- Employees
- 2,000
- Founded
- 1981
- Headquarters
- Waltham, United States of America
What 5 Arbolus experts think of Repligen Corporation
5 customers have reviewed Repligen Corporation so far. The full customer report is in progress and publishes once enough customers have been interviewed in depth.
Who reviewed Repligen Corporation
- C-Suite 20% (1)
- Director 40% (2)
- Manager 40% (2)
Employer names and spend open once the report publishes.
Tell us when the Repligen Corporation report publishes.
We'll email you once the full customer report is ready, with employer names, spend and every written answer. No account needed.
Sentiment
60 Net Promoter Score, from 5 scored reviews- Promoters 4
- Passives 0
- Detractors 1
Cumulative NPS by month
-1 over 5 months- Aug 9
- Mar 9
- May 9
- Jun 8
- Aug 8
Net Promoter Score across 1 reviews, accumulated up to each month. Category median 60 across 1 companies.
Written answers and themes publish with the full report.
Renewal intent
Plan to renew 100%Plan to renew, by seniority
- 100% 1 answer
- 100% 2 answers
- 100% 1 answer
- 7.8/10 Average score from customers who will renew
For people who use Repligen Corporation
Do you use Repligen Corporation at work?
Share your software review and get matched to paid projects. Arbolus pays you every time a client reads your review.
- 5 customers of Repligen Corporation have already contributed
Takes a few minutes. Your identity stays anonymous.